The Recall Desk

FDA (Drugs) recall action 83136

Infusion Options, Inc. recalled 76 products on 2019-08-21

The FDA (Drugs) publishes a recall like this one as 76 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 76 pages.

Products
76
Announced
2019-08-21
Critical
0
Units
—

Why these products were recalled

Lack of Assurance of Sterility

The agency’s own wording, quoted from the enforcement report.

States named across these recalls

1–25 of 76

  • SevereFDA (Drugs)··2019-08-21

    Adcetris IV Infusion Recalled for Lack of Sterility Assurance

    Infusion Options, Inc. is recalling Adcetris 96 mg/100 mL IV infusion bags due to a lack of assurance of sterility. The product was distributed in New York.

    Product
    Adcetris 96 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Calcium Glucunate IV Bags Due to Sterility Concerns

    Infusion Options, Inc. is recalling Calcium Glucunate 1 gm/100 mL IV bags in New York due to a lack of assurance of sterility.

    Product
    CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Durvalumab Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling Durvalumab infusions in New York due to a lack of assurance of sterility.

    Product
    Durvalumab 651 mg/ 250 ml NS IVPB; Durvalumab 650 mg/ 250 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Rituximab Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling specific Rituximab infusion bags in New York due to a lack of assurance of sterility.

    Product
    RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 675 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 1000 MG / 1000 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Fluorouracil Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Fluorouracil infusion products due to a lack of assurance of sterility. The recall is limited to New York.

    Product
    Fluorouracil 560 MG / 11.2 ML IVP; Fluorouracil 3340 MG QS 92 ML 0.9% NACL; Fluorouracil 3920 MG QS 92 ML 0.9% NACL; Fluorouracil 3760 mg QS 100 ml NS CASS; Fluorouracil 4000 MG QS 92 ml 0.9% NACL; Fluorouracil 3140 MG QS 240 ML NS PUMP; Fluorouracil 2400 MG QS 96 ML 0.9% NACL F
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Velcade Syringes Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Velcade subcutaneous syringes in New York due to a lack of assurance of sterility.

    Product
    VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE 2.2 MG/ 0.88 ML SUB-Q SYRINGE; VELCADE 2.6 MG (1.04 ML) Sub Q SYRINGE; VELCADE 4 mg / 1.6 ml SQ SYRINGE; VELCADE 2.75 mg / 1.1 ml SQ SYRINGE; VELCADE 2.6 mg / 1.04 ml SQ SYRINGE VELCADE 1.7 mg / 0.6
    Category
    Distribution
    1 state
  • HighFDA (Drugs)··2019-08-21

    Infusion Options Recalls HERCEPTIN Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling HERCEPTIN infusion bags in New York due to a lack of assurance of sterility.

    Product
    HERCEPTIN 400 MG / 250 ML NS IVPB; HERCEPTIN 340 MG /250 ml 0.9% NACL IVPB; HERCEPTIN 553 MG / 250 ml NS IVPB; HERCEPTIN 305 MG / 250 ml NS IVPB; HERCEPTIN 526 MG / 250 ML NS IVPB; HERCEPTIN 162 MG / 250 ML NS IVPB; HERCEPTIN 354 MG/ 250 ml 0.9% NACL IVPB; HERCEPTIN 440 MG / 250
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Pemetrexed Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling Pemetrexed infusion products in New York due to a lack of assurance of sterility.

    Product
    PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB; PEMETREXED 490 MG /100 ml NS IVPB; PEMETREXED 800 mg/ 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Dexamethasone Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling specific dexamethasone infusion products in New York due to a lack of assurance of sterility.

    Product
    DEXAMETHASONE 10 MG / 50 ML NS IVPB; DEXAMETHASONE 5 MG / 50 ML NS; DEXAMETHASONE 5 MG / 50 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Doxorubicin Syringes Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Doxorubicin IV syringes in New York due to a lack of assurance of sterility.

    Product
    Doxorubicin 110 MG / 55 ML IVP SYRINGE; Doxorubicin 56 MG / 28 ML IVP SYRINGE; Doxorubicin 75 MG / 37.5 ML IVP SYRINGE; Doxorubicin 125 MG / 62.5 ML SYRINGE IVP; Doxorubicin 93 MG / 46.5 ML IV SYRINGE; Doxorubicin 112 MG / 56 ML IVP SYRINGE; Doxorubicin 50 MG / 25 ML IVP SYRINGE;
    Category
    Distribution
    1 state
  • HighFDA (Drugs)··2019-08-21

    Infusion Options Recalls Cyclophosphamide Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Cyclophosphamide infusion products in New York due to a lack of assurance of sterility.

    Product
    Cyclophosphamide 840 MG / 250 ML NS IVPB; Cyclophosphamide 1112 MG / 250 ML NS IVPB; Cyclophosphamide 1248 MG / 50 ML NS IVPB; Cyclophosphamide 1125 MG / 100 ML NS IVPB; Cyclophosphamide 1000 MG / 500 ML NS IVPB; Cyclophosphamide 1400 MG / 100 ML NS IVPB Cyclophosphamide 1056 MG
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls RomiPLOStim Syringes Due to Sterility Concerns

    Infusion Options, Inc. is recalling RomiPLOStim 700 MCG/1.4 ML SQ syringes in New York due to a lack of assurance of sterility.

    Product
    RomiPLOStim 700 MCG/ 1.4 ML SQ SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Oxytocin IV Solution Due to Sterility Concerns

    Infusion Options, Inc. is recalling Oxytocin 60 units/1000 mL Lactated Ringers IV Solution because the product lacks assurance of sterility. The recall affects 820 bags distributed in New York.

    Product
    Oxytocin 60 units/1000 mL Lactated Ringers Intravenous Solution, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Etoposide Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Etoposide infusion bags in New York due to a lack of assurance of sterility.

    Product
    Etoposide 184 MG / 500 ml NS IVPB; Etoposide 176 MG/ 500 ml 0.9% NACL IVPB; Etoposide 170 MG / 500 ml 0.9% NACL IVPB; Etoposide 152 MG / 500 ml 0.9% NACL IVPB; Etoposide 275 MG / 500 ml NS IVPB; Etoposide 270 MG / 500 ml NS IVPB; Etoposide 90 MG / 500 ml NS IVPB; Etoposide 160 MG
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Trastuzumab Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling specific trastuzumab and emtansine infusion products in New York due to a lack of assurance of sterility.

    Product
    ADO-TRASTUZUMAB 210 MG/250 ml NS; ADO-TRASTUZUMAB E 213 MG / 250 ML NS; ADO-TRASTUZUMAB 242 MG/250 ml NS; ADO-TRASTUZUMAB EMT 168 mg / 250 ml NS; ADO-TRASTUZUMAB E 160 MG / 250 ML NS ADO-TRASTUZUMAB 150 mg / 250 ml NS; ADO-TRASTUZUMAB EMT 301 mg / 250 ml NS; ADO-TRASTUZUMAB EMTA
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Cisplatin Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Cisplatin infusion products due to a lack of assurance of sterility. The recall is limited to New York.

    Product
    Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.9% NACL; Cisplatin 44 MG QS 500 ml NS IVPB; Cisplatin 40 MG / 500 ml 0.9% NACL; Cisplatin 36 MG / 500 ML NS IVPB; Cisplatin 73 MG QS 500 ml 0.9% NACL WITH Mannitol 12.5 G; Cisplatin 70 MG / 500 ml NS
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Irinotecan Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Irinotecan infusion products in New York due to a lack of assurance of sterility.

    Product
    IRINOTECAN 250 MG /500 ml D5W IVPB; IRINOTECAN 110 MG /250 ML D5W IVPB; IIRINOTECAN 250 MG/250 ML NS IVPB; IRINOTECAN 315 MG / 250 ML NS IVPB; IRINOTECAN 155 MG / 500 ml D5W IVPB; IRINOTECAN 75 MG / 250 ML NS IVPB; IRINOTECAN 140 MG / 250 ML NS IVPB; IRINOTECAN 317 MG /500 ML D5W
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Fluorouracil Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Fluorouracil infusion products in New York due to a lack of assurance of sterility.

    Product
    Fluorouracil 560 MG / 11.2 ML IVP Fluorouracil 3340 MG QS 92 ML 0.9% NACL Fluorouracil 3920 MG QS 92 ML 0.9% NACL Fluorouracil 3760 mg QS 100 ml NS CASS Fluorouracil 4000 MG QS 92 ml 0.9% NACL Fluorouracil 3140 MG QS 240 ML NS PUMP Fluorouracil 2400 MG QS 96 ML 0.9% NACL F
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Paclitaxel Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Paclitaxel infusion bags in New York due to a lack of assurance of sterility.

    Product
    PACLITAXEL 258 MG / 500 ML NS IVPB; PACLITAXEL 318 MG / 500 ML NS IVPB; PACLITAXEL 385 MG / 500 ML NS IVPB; PACLITAXEL 340 MG / 500 ML NS IVPB; PACLITAXEL 332 MG / 500 ML NS IVPB; PACLITAXEL 250 MG / 500 ML NS IVPB; PACLITAXEL 117 MG / 250 ML NACL 0.9% IVPB PACLITAXEL 90 MG / 25
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Abraxane Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling specific Abraxane infusion bags in New York due to a lack of assurance of sterility.

    Product
    Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Oxaliplatin Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling multiple lots of oxaliplatin infusion bags due to a lack of assurance of sterility. The recall is limited to New York.

    Product
    OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALIPLATIN 130 MG / 250 ML D5W IVPB; OXALIPLATIN 140 MG / 250 ml D5W IVPB; OXALIPLATIN 162 MG / 250 ML D5W IVPB; OXALIPLATIN 169 MG / 250 ML D5W IVPB; OXALIPLATIN 90 MG / 500 ML D5W IVPB; OXALIPLATIN 50 M
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Leucovorin Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Leucovorin intravenous infusion bags due to a lack of assurance of sterility. The products were distributed in New York.

    Product
    LEUCOVORIN 560 MG / 250 ML NS IVPB; LEUCOVORIN 830 MG / 250 ml NS IVPB; LEUCOVORIN 300 MG / 50 ml D5W IVPB; LEUCOVORIN 840 MG / 250 ml NS IVPB; LEUCOVORIN 750 MG / 250 ml NS IVPB; LEUCOVORIN 690 MG / 250 ml NS IVPB; LEUCOVORIN 314 mg / 50 ml NS IVPB; LEUCOVORIN 620 MG / 250 ml D5
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Eribulin Infusions Due to Sterility Concerns

    Infusion Options, Inc. is recalling specific Eribulin infusion products in New York due to a lack of assurance of sterility.

    Product
    ERIBULIN 1.12 MG / 100 ML NS IVPB; ERIBULIN 1.87 MG / 100 ML NS IVPB; ERIBULIN 1.89 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Methotrexate Injections Due to Sterility Concerns

    Infusion Options, Inc. is recalling various Methotrexate injection products in New York due to a lack of assurance of sterility.

    Product
    METHOTREXATE 25 MG / 1 ML IM SYR; METHOTREXATE 12 mg QS 5 ml PF 0.9% NACL; METHOTREXATE 98 MG / 3.92 ML IM SYR; METHOTREXATE 55 MG / 2.2 ML IVP; METHOTREXATE 59.5 MG / 2.38 ML IVP; METHOTREXATE 12 mg QS 6 ml 0.9% NACL; METHOTREXATE 150 MG / 50 ML NS IVPB; METHOTREXATE 112.5 MG/ 4
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2019-08-21

    Infusion Options Recalls Mitomycin Syringes Due to Sterility Concerns

    Infusion Options, Inc. is recalling Mitomycin 10 mg/20 mL IVP syringes in New York due to a lack of assurance of sterility.

    Product
    MITOMYCIN 10 MG /20 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
    Category
    Distribution
    1 state